Skip to menu Skip to content Skip to footer
Professor Denise Doolan
Professor

Denise Doolan

Email: 
Phone: 
+61 7 334 62159

Overview

Background

Professor Denise Doolan is Director of Research at the Institute for Molecular Bioscience. She joined IMB in 2022 and was previously Deputy Director of the Australian Institute of Tropical Health and Medicine, and Director of the JCU Centre for Molecular Therapeutics, at James Cook University.

She is a molecular immunologist, working on the development of vaccines, diagnostics and host-directed therapeutics for infectious and chronic diseases that impact global public health, with a particular focus on malaria. Her cross-disciplinary research program spans host-pathogen immunity, antigen discovery, vaccine engineering, and biomarker discovery. A particular interest is the application of state-of-the-art genome-based technologies and human models of disease system to identify novel targets for intervention against disease or that predict risk of disease.

She is a recognized world expert in malaria immunology, vaccinology, and omic-based approaches for therapeutic and diagnostic development. She has been honoured as a Fellow of the International Society for Vaccines (2017) and a Fellow of the Australian Society of Parasitology (2019) in recognition of her leadership and contribution to health and medical science in Australia and internationally.

Professor Doolan serves on a number of Executive Boards and Advisory Boards. Most recently, she has been elected as President of the International Society for Vaccines (2021-2023), and has been appointed to the Federal Government’s Australian Medical Research Advisory Board (AMRAB; 2021-2026) to provide specialist insights into Australia’s medical research and innovation priorities.

Availability

Professor Denise Doolan is:
Available for supervision

Fields of research

Qualifications

  • Bachelor of Science, The University of Queensland
  • B Sc Hons (Biochemistry), The University of Queensland
  • M Phil (Life Sciences), Griffith University
  • PhD (Molecular Immunology), The University of Queensland

Works

Search Professor Denise Doolan’s works on UQ eSpace

218 works between 1987 and 2024

201 - 218 of 218 works

1996

Journal Article

Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1

Doolan, D. L., Hedstrom, R. C., Rogers, W. O., Charoenvit, Y., Rogers, M., de la Vega, P. and Hoffman, S. L. (1996). Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1. The Journal of Biological Chemistry, 271 (30), 17861-17868. doi: 10.1074/jbc.271.30.17861

Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1

1996

Journal Article

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

Doolan, D. L., Sedegah, M., Hedstrom, R. C., Hobart, P., Charoenvit, Y. and Hoffman, S. L. (1996). Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. The Journal of Experimental Medicine, 183 (4), 1739-1746. doi: 10.1084/jem.183.4.1739

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

1996

Journal Article

DNA vaccines against malaria: Immunogenicity and protection in a rodent model

Gardner, Malcolm J., Doolan, Denise L., Hedstrom, Richard C., Wang, Ruobing, Sedegah, Martha, Gramzinski, Robert A., Aguiar, Joao C., Wang, Helen, Margalith, Michal, Hobart, Peter and Hoffman, Stephen L. (1996). DNA vaccines against malaria: Immunogenicity and protection in a rodent model. Journal of Pharmaceutical Sciences, 85 (12), 1294-1300. doi: 10.1021/js960147h

DNA vaccines against malaria: Immunogenicity and protection in a rodent model

1995

Journal Article

Nucleic Acid Malaria Vaccines: Current Status and Potential

HOFFMAN, S. L., DOOLAN, D. L., SEDEGAH, M., GRAMZINSKI, R., WANG, H., GOWDA, K., HOBART, P., MARGALITH, M., NORMAN, J. and HEDSTROM, R. C. (1995). Nucleic Acid Malaria Vaccines: Current Status and Potential. Annals of the New York Academy of Sciences, 772 (1), 88-94. doi: 10.1111/j.1749-6632.1995.tb44734.x

Nucleic Acid Malaria Vaccines: Current Status and Potential

1994

Journal Article

Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus

Argaet, V P, Schmidt, C W, Burrows, S R, Silins, S L, Kurilla, M G, Doolan, D L, Suhrbier, A, Moss, D J, Kieff, E, Sculley, T B and Misko, I S (1994). Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. The Journal of Experimental Medicine, 180 (6), 2335-2340. doi: 10.1084/jem.180.6.2335

Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus

1994

Journal Article

Evidence for limited activation of distinct CD4+ T cell subsets in response to the Plasmodium falciparum circumsporozoite protein in Papua New Guinea

Doolan, D. L., Beck, H. P. and Good, M. F. (1994). Evidence for limited activation of distinct CD4+ T cell subsets in response to the Plasmodium falciparum circumsporozoite protein in Papua New Guinea. Parasite Immunology, 16 (3), 129-136. doi: 10.1111/j.1365-3024.1994.tb00332.x

Evidence for limited activation of distinct CD4+ T cell subsets in response to the Plasmodium falciparum circumsporozoite protein in Papua New Guinea

1993

Journal Article

Developing a malaria sporozoite vaccine

Doolan, D. L. and Good, M. F. (1993). Developing a malaria sporozoite vaccine. Today's Life Science, 5 (6), 18-27.

Developing a malaria sporozoite vaccine

1993

Journal Article

Cytotoxic T lymphocyte (CTL) low-responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally-exposed endemic populations: analysis of human CTL response to most known variants

Doolan, D. L., Khamboonruang, C., Beck, H. P., Houghten, R. A. and Good, M. F. (1993). Cytotoxic T lymphocyte (CTL) low-responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally-exposed endemic populations: analysis of human CTL response to most known variants. International Immunology, 5 (1), 37-46. doi: 10.1093/intimm/5.1.37

Cytotoxic T lymphocyte (CTL) low-responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally-exposed endemic populations: analysis of human CTL response to most known variants

1992

Journal Article

Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development

Doolan, D. L., Saul, A. J. and Good, M. F. (1992). Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development. Infection and Immunity, 60 (2), 675-682. doi: 10.1128/iai.60.2.675-682.1992

Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development

1992

Journal Article

Plasmodium falciparum CS protein--prime malaria vaccine candidate: definition of the human CTL domain and analysis of its variation

Doolan, D. L. and Good, M. F. (1992). Plasmodium falciparum CS protein--prime malaria vaccine candidate: definition of the human CTL domain and analysis of its variation. Memorias do Instituto Oswaldo Cruz, 87 Suppl 3, 241-247. doi: 10.1590/s0074-02761992000700040

Plasmodium falciparum CS protein--prime malaria vaccine candidate: definition of the human CTL domain and analysis of its variation

1991

Journal Article

Location of human cytotoxic T cell epitopes within a polymorphic domain of the Plasmodium falciparum circumsporozoite protein

Doolan, D. L., Houghten, R. A. and Good, M. F. (1991). Location of human cytotoxic T cell epitopes within a polymorphic domain of the Plasmodium falciparum circumsporozoite protein. International Immunology, 3 (6), 511-516. doi: 10.1093/intimm/3.6.511

Location of human cytotoxic T cell epitopes within a polymorphic domain of the Plasmodium falciparum circumsporozoite protein

1991

Journal Article

Proteins of bovine ephemeral fever virus

Walker, P. J., Byrne, K. A., Cybinski, D. H., Doolan, D. L. and Wang, Y. H. (1991). Proteins of bovine ephemeral fever virus. Journal of General Virology, 72 ( Pt 1) (1), 67-74. doi: 10.1099/0022-1317-72-1-67

Proteins of bovine ephemeral fever virus

1991

Journal Article

Assessment of human cytotoxic T cell activity using synthetic peptides: potential for field application

Doolan, D. L., Houghten, R. A. and Good, M. F. (1991). Assessment of human cytotoxic T cell activity using synthetic peptides: potential for field application. Peptide Research, 4 (3), 125-131.

Assessment of human cytotoxic T cell activity using synthetic peptides: potential for field application

1988

Conference Publication

Trace element and macro electrolyte behaviour during inflammatory diseases in cattle and sheep

Murphy, G. M., St. George, T. D., Guerrini, V., Collins, R. G., Broadmeadow, A. C., Uren, M. F. and Doolan, D. L. (1988). Trace element and macro electrolyte behaviour during inflammatory diseases in cattle and sheep. Sixth International Symposium on Trace Elements in Man and Animals, Pacific Grove, CA, United States, 31 May-5 June 1987. New York, NY, United States: Plenum Press.

Trace element and macro electrolyte behaviour during inflammatory diseases in cattle and sheep

1987

Journal Article

Amino-Acid Supply and Protein-Metabolism in Ehrlich Ascites Tumor-Cells .1. Identification of Limiting Amino-Acids

Doolan, DL and Ward, LC (1987). Amino-Acid Supply and Protein-Metabolism in Ehrlich Ascites Tumor-Cells .1. Identification of Limiting Amino-Acids. Cytobios, 51 (204), 7-23.

Amino-Acid Supply and Protein-Metabolism in Ehrlich Ascites Tumor-Cells .1. Identification of Limiting Amino-Acids

1987

Journal Article

Amino acid supply and protein metabolism in Ehrlich ascites tumour cells. 2 Incorporation of 14C-tyrosine

Doolan, D. L. and Ward, L. C. (1987). Amino acid supply and protein metabolism in Ehrlich ascites tumour cells. 2 Incorporation of 14C-tyrosine. Cytobios, 50 (204), 49-61.

Amino acid supply and protein metabolism in Ehrlich ascites tumour cells. 2 Incorporation of 14C-tyrosine

1987

Journal Article

Amino-Acid Supply and Protein-Metabolism in Ehrlich Ascites Tumor-Cells .2. Incorporation of C-14 Tyrosine

Doolan, DL and Ward, LC (1987). Amino-Acid Supply and Protein-Metabolism in Ehrlich Ascites Tumor-Cells .2. Incorporation of C-14 Tyrosine. Cytobios, 51 (204), 49-61.

Amino-Acid Supply and Protein-Metabolism in Ehrlich Ascites Tumor-Cells .2. Incorporation of C-14 Tyrosine

1987

Journal Article

Amino acid supply and protein metabolism in Ehrlich ascites tumour cells. 2. Incorporation of 14C-tyrosine

Doolan, D. L. and Ward, L. C. (1987). Amino acid supply and protein metabolism in Ehrlich ascites tumour cells. 2. Incorporation of 14C-tyrosine. Cytobios, 51 (204), 49-61.

Amino acid supply and protein metabolism in Ehrlich ascites tumour cells. 2. Incorporation of 14C-tyrosine

Funding

Current funding

  • 2024 - 2026
    Effective Multiple Sclerosis diagnosis based on EBV proteome screening
    MS Research Australia Project Grant
    Open grant

Past funding

  • 2023 - 2024
    Human-informed data-driven development of next-generation T cell vaccine against malaria
    United States National Institutes of Health
    Open grant
  • 2013 - 2017
    Tropical disease - immunity, pathogenesis and vaccine development: global translation (NHMRC Program Grant administered by Griffith University)
    Griffith University
    Open grant
  • 2012 - 2014
    ResTeach Funding 2012 0.1 FTE School of Medicine/School of Chemisty and Molecular Biosciences
    UQ ResTeach
    Open grant

Supervision

Availability

Professor Denise Doolan is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • UNDERSTANDING THE LINK BETWEEN EBV AND MULTIPLE SCLEROSIS

    An opportunity exists for a PhD position in molecular immunology, where cutting-edge technologies will be applied to understand the molecular basis of the link between EBV and Multiple Sclerosis. Epstein-Barr virus (EBV) is the top identified causative agent of Multiple Sclerosis, but how this occurs is not known. This project aims to apply an innovative approach using proteome-wide screening of EBV to identify the subset of EBV proteins from the complete EBV proteome that triggers MS. It will compare responses in individuals with different stages of MS and apply sophisticated computational analytics to identify specific EBV proteins that predict MS disease. This EBV signature of MS could be translated into a clinic-friendly point-of-care test. If successful, this project could revolutionize the diagnosis and management of MS, providing patients with a quicker and more accurate diagnosis and enhanced quality of life.

    Subject areas: Immunology, Molecular immunology, Systems biology, Multiple Sclerosis, Autoimmunity, EBV

    Eligibility: Entry: Bachelor degree with Honours Class I (or equivalent via outstanding record of professional or research achievements) Experience/Background: laboratory-based experience in immunology, host-pathogen interactions, immune regulation and infectious diseases; excellent computer, communication, and organisational skills are required.

    Supervisors:

    Professor Denise Doolan & Dr Carla Proietti

  • MOLECULAR IMMUNOLOGY OF MALARIA

    An opportunity exists for a PhD position in the molecular immunology of malaria. The focus of this project will be to apply cutting-edge technologies to understand the molecular basis of protective immunity to malaria. It will take advantage of controlled human infection models and as well as animal models to explore the mechanisms underlying protective immunity to malaria and immune responsiveness. Using a range of interdisciplinary approaches, including immune profiling, transcriptomics, proteomics, and small molecule characterization, the project aims to define the critical cells and signalling pathways required for protective immunity against malaria. It is anticipated that this research will have broad application to a wide range of infectious and chronic diseases, with important implications for vaccination.

    Subject areas: Immunology, Molecular immunology, Systems biology, Vaccinology, Malaria

    Eligibility: Entry: Bachelor degree with Honours Class I (or equivalent via outstanding record of professional or research achievements) Experience/Background: laboratory-based experience in immunology, host-pathogen interactions, immune regulation and infectious diseases; excellent computer, communication, and organisational skills are required.

    Supervisors:

    Professor Denise Doolan (IMB) & Dr Carla Proietti (IMB)

  • VACCINE ENGINEERING

    An opportunity exists for a PhD position in vaccine engineering. Vaccines are one of the most effective health care interventions but remain a challenge for many diseases, and in particular intracellular pathogens such as malaria where T cell responses are particularly desirable. We have been exploring novel approaches to rationally design an effective vaccine against challenging disease targets. By taking advantage of recent advances in genomic sequencing, proteomics, transcriptional profiling, and molecular immunology, we have discovered unique targets of T cell responses or antibody response. This project will test these antigens as vaccine candidates by assessing immunogenicity, protective capacity and biological function using different vaccine platforms. By designing an effective vaccine from genomic data, this project is expected to result in significance advances in vaccinology as well as immunology, with important public health outcomes.

    Subject areas: Immunology, Vaccinology, Molecular immunology, Malaria, Vaccine engineering, Vaccine design

    Eligibility: Entry: Bachelor degree with Honours Class I (or equivalent via outstanding record of professional or research achievements) Experience/Background: laboratory-based experience in immunology, host-pathogen interactions, immune regulation and infectious diseases; excellent computer, communication, and organisational skills are required.

    Supervisor:

    Professor Denise Doolan (IMB) & Professor Carla Proietti (IMB)

  • SYSTEMS IMMUNOLOGY AND MULTI-OMICS APPROACHES TO UNDERSTAND PROTECTIVE IMMUNITY TO HUMAN MALARIA

    This PhD project aims to develop and apply computational approaches that integrate systems biology and molecular immunology to understand host-pathogen immunity and predict immune control of malaria. The project will utilise systems-based immunology and multi-omics approaches to profile the host immune response in controlled infection models of malaria at molecular, cellular, transcriptome and proteome-wide scale.

    The overall aim will be to develop and apply omics-based technologies and computational tools, including network theory and machine learning, to integrate multiple high-dimensional datasets and reveal novel insights into host-pathogen immunity and predict immune responsiveness and parasite control. Modelling of large-scale existing datasets, including those generated by single-cell RNA-sequencing technologies, may also be a feature of this project. The opportunity to identify new knowledge and integrate this with experimental data produced by our laboratory will be instrumental to extending the impact of these bioinformatics analyses. This project will provide an opportunity to be at the forefront in cutting-edge technologies and advances in computational analysis of integrated high-dimensional omic data.

    Methodologies: Bioinformatics, Machine Learning, Immunology, Systems Immunology, Systems Biology, Genomics/Proteomics/Transcriptomics, Molecular and Cell Biology, Statistics

    Eligibility: Entry: BSc Honours Class I (or equivalent via outstanding record of professional or research achievements) Experience/Background: Experience with programming languages, mathematics, statistics and/or background in immunology and molecular sciences, with an interest in integrating the fields of immunology and bioinformatics.

    Excellent computer, communication, and organisational skills are required. Forward thinking, innovation and creativity are encouraged.

    Supervisors:

    Professor Denise Doolan (IMB) & Dr Carla Proietti (IMB)

    Associate Professor Jessica Mar (AIBN)

Supervision history

Current supervision

  • Doctor Philosophy

    Defining the molecular basis of immune heterogeneity between individuals using immunoproteomics

    Principal Advisor

  • Doctor Philosophy

    Systems immunology and multi-omics approaches to understand protective immunity to human malaria

    Principal Advisor

Completed supervision

Media

Enquiries

For media enquiries about Professor Denise Doolan's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au